Meeting
2023 ASCO Annual Meeting
Distinguishing primary mucinous ovarian tumors from metastases of non-gynecologic mucinous cancers: Can we leverage next-generation sequencing?
Authors
Muhammad Danyal Ahsan
Weill Cornell Medicine - Qatar, Doha, Qatar
Muhammad Danyal Ahsan , Murtaza Qazi , Ryan M Kahn , Emily M Webster , Sarah R. Levi , Benedict Harvey , Luiza Perez , Jesse T Brewer , Laura Keenahan , Gaurav Thareja , Ravi N. Sharaf , Evelyn Cantillo , Eloise Chapman-Davis , Melissa Kristen Frey , Dennis S Chi , Kevin Holcomb
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Ovarian Cancer
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 5582)
DOI
10.1200/JCO.2023.41.16_suppl.5582
Abstract #
5582
Poster Bd #
277
Abstract Disclosures
Similar Posters
Poster
2011 ASCO Annual Meeting
Comprehensive next-generation sequencing for clinically actionable mutations from formalin-fixed cancer tissues.
First Author: J. S. Ross
Poster
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
First Author: Razelle Kurzrock
Poster
2014 ASCO Annual Meeting
Comprehensive genomic profiling of gallbladder adenocarcinoma and frequent genomic-derived targets of therapy.
First Author: Phil Stephens
Poster
2024 ASCO Genitourinary Cancers Symposium
Comprehensive analysis of targetable alterations in urachal cancer by NGS.
First Author: David Joseph Benjamin